Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Buy
78,459
+1,776
+2% +$64.3K 0.28% 97
2026
Q1
$2.78M Buy
76,683
+1,023
+1% +$37.9K 0.29% 94
2025
Q4
$2.36M Buy
75,660
+962
+1% +$29.8K 0.26% 96
2025
Q3
$2.46K Buy
74,698
+6,356
+9% +$221K ﹤0.01% 165
2025
Q2
$2.21M Buy
68,342
+2,481
+4% +$85.9K 0.26% 91
2025
Q1
$2.45M Buy
65,861
+830
+1% +$34.3K 0.31% 80
2024
Q4
$2.66M Buy
65,031
+58
+0.1% +$2.81K 0.32% 81
2024
Q3
$3.27M Sell
64,973
-17,627
-21% -$809K 0.39% 66
2024
Q2
$3.61M Sell
82,600
-79
-0.1% -$3.46K 0.42% 68
2024
Q1
$3.59M Buy
82,679
+26,363
+47% +$1.03M 0.41% 70
2023
Q4
$2.34M Buy
56,316
+3,473
+7% +$121K 0.3% 74
2023
Q3
$1.87M Buy
52,843
+2,034
+4% +$78.8K 0.27% 79
2023
Q2
$2.08M Sell
50,809
-158
-0.3% -$6.19K 0.28% 79
2023
Q1
$2.1M Buy
50,967
+1,896
+4% +$75.6K 0.3% 68
2022
Q4
$1.66M Buy
49,071
+2,152
+5% +$70.7K 0.25% 89
2022
Q3
$1.42M Buy
+46,919
New +$1.94M 0.24% 91

Other funds holding AVNT

Isthmus Partners's AVNT Position: Q2 2026 in Review

Isthmus Partners increased its Avient (AVNT) stake by 2.3% in Q2 2026, buying an estimated $64.3K and bringing the position to 78,459 shares worth $2.9M. The position accounts for 0.28% of the portfolio, ranked #97.

Isthmus Partners first reported a position in AVNT in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.61M in Q2 2024. 347 funds tracked by Wall St. Rank hold AVNT as of Q2 2026.

  • Isthmus Partners held 78,459 shares of Avient worth $2.9M as of Q2 2026.
  • Isthmus Partners bought 1,776 Avient shares in Q2 2026, an estimated $64.3K.
  • Avient made up 0.28% of Isthmus Partners's portfolio in Q2 2026, its #97 holding.
  • Isthmus Partners first reported a position in Avient in Q3 2022 and has held it in 16 quarters since.
  • Isthmus Partners's Avient position peaked at $3.61M in Q2 2024.
  • 347 funds tracked by Wall St. Rank held Avient as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.